Skip to main content
. 2005 Sep 1;96(10):653–660. doi: 10.1111/j.1349-7006.2005.00091.x

Figure 2.

Figure 2

Overall survival curves for 86 patients with neuroblastoma who were found clinically. (a) Overall survival curves for 22 patients with a serum NM23‐H1 level ≥ 250 ng/mL, and for 64 patients with a level < 250 ng/mL. (b) Overall survival curves for 57 patients 12 months of age or older, and for 29 patients younger than 12 months. (c) Overall survival curves for 65 patients at stages 3 and 4 of the disease, and for 21 patients at stages 1, 2 and 4s. (d) Overall survival curves for 27 patients with MYCN amplification, and for 59 patients with a single copy of MYCN. GW, generalized Wilcoxon's test; LR, log‐rank test.